ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022 Press release … at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022 LEIDEN, Netherlands & CAMBRIDGE, Mass., May 09, … Maio 09, 2022
ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 Press release … ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 LEIDEN, Netherlands & CAMBRIDGE, Mass., May 09, 2023 … Maio 09, 2023
Development of RNA Base Editing Technologies for Precision Medicines Presentation … Medicines with Axiomer® and Trident® presented at TIDES USA 2022 by Gerard Platenburg - ProQR Therapeutics. … Maio 11, 2022
Unlocking the Potential of Innovative Editing Oligonucleotides (EONs) to Address Liver Originated Disorders Presentation The presentation reviews EONs structure activity, the potential of the Axiomer platform as well as its applicability for the treatment of liver originated disorders. Presented at TIDES USA on May 9, 2023 by Gerard Platenburg - ProQR Therapeutics. Maio 09, 2023
ProQR Announces First Quarter 2023 Operating and Financial Results Press release … at the Oligonucleotide and Peptide Therapeutics conference (TIDES USA). In March, ProQR announced the successful defense of a … Maio 16, 2023
ProQR Announces Second Quarter 2022 Operating and Financial Results Press release … at the Oligonucleotide and Peptide Therapeutics conference (TIDES USA). Business updates In conjunction with the Annual General … Agosto 04, 2022
